Eighteen months after Novo Nordisk purchased a plant in the Czech Republic from Novavax, the Danish drugmaker said it is set to kick off the manufacturing of ingredients for next-generation diabetes and obesity drugs at the facility. The company also announced locally that it will invest $29 million in its plant in China.
Novo Nordisk opens Czech plant and unveils $29M upgrade to China facility
Latest from Blog
Why Walmart Moved ALOHA From the Nutrition Aisle to Grocery
Nosh spoke with company leaders about what prompted the move, how they’ll measure success and why they believe protein bars are increasingly becoming just another grocery staple. Post Views: 2
RFK Jr. Talks Nutrition In Holland
(Holland, MI) – U.S. Health and Human Services Secretary Robert F. Kennedy Jr. discussed nutrition and food ac… Post Views: 2
5 Risky Wellness Trends Doctors Want You to Avoid
Bee venom therapy and raw milk are among some of the worst wellness trends this year. Post Views: 2
Stratum Nutrition gains authorization in Canada for Ovolux skin health claims
Stratum Nutrition’s eggshell membrane ingredient for beauty-from-within applications, Ovolux, has achieved authorization for multiple skin health claims from Health Canada. Manufacturers using the ingredient can use claims that Ovolux helps to improve, increase,
From Chile to the world: Food policy package linked to lower childhood obesity risk
Chile’s integrated food policies — FOP warning labels, marketing restrictions for children, and school food rules — reduced excess weight risk in children by ~2% after the FLAL law. Girls and boys exposed